Evidence map›Paper›PMID 41951598›Full record

ArticleTranslational psychiatry2026

The social dimension of apathy: evidence for a distinct domain from 11,243 individuals across health and neurocognitive disorders.

Sijia Zhao, Rong Ye, Qian-Yuan Tang, Bahaaeddin Attaallah, Sofia Toniolo, Youssuf Saleh, Matthew A Rouse, Peter Garrard, M John Broulidakis, Sian Thompson and 10 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sijia ZhaoDepartment of Experimental Psychology, University of Oxford, Oxford, OX1 3EL, UK. sijia.zhao@psy.ox.ac.uk.ORCID http://orcid.org/0000-0002-6246-0702
Rong YeDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.ORCID http://orcid.org/0000-0003-2529-7755
Qian-Yuan TangDepartment of Physics, Hong Kong Baptist University, Hong Kong, China.
Bahaaeddin AttaallahDepartment of Brain Sciences, Imperial College London, London, W12 0BZ, UK.
Sofia TonioloNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.
Youssuf SalehNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.
Matthew A RouseMRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK.
Peter GarrardSchool of Health and Medical Sciences, City St George's, University of London, London, SW17 0RE, UK.
M John BroulidakisDepartment of Experimental Psychology, University of Oxford, Oxford, OX1 3EL, UK.
Sian ThompsonCognitive Disorders Clinic, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Sanjay G ManoharDepartment of Experimental Psychology, University of Oxford, Oxford, OX1 3EL, UK.
Sarosh R IraniNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.ORCID http://orcid.org/0000-0002-7667-9748
Yuen-Siang AngSocial and Cognitive Computing Department, Institute of High Performance Computing, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Patricia LockwoodCentre for Human Brain Health, School of Psychology, University of Birmingham, Birmingham, B15 2TT, UK.ORCID http://orcid.org/0000-0001-7195-9559
Matthew A J AppsCentre for Human Brain Health, School of Psychology, University of Birmingham, Birmingham, B15 2TT, UK.
Panpan HuDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Kai WangDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.ORCID http://orcid.org/0000-0002-6197-914X
James B RoweMRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK.
Campbell Le HeronDepartment of Medicine, University of Otago, Christchurch, New Zealand.
Masud HusainDepartment of Experimental Psychology, University of Oxford, Oxford, OX1 3EL, UK.

Funding

Canterbury Medical Research Foundation (CMRF) 02/2019National Natural Science Foundation of China (National Science Foundation of China) 82171917National Natural Science Foundation of China (National Science Foundation of China) 82471271RCUK | Medical Research Council (MRC) MC_UU_00030/14RCUK | Medical Research Council (MRC) MR/V007173/1RCUK | Medical Research Council (MRC) SUAG/092 G116768Wellcome Trust 220258Wellcome Trust (Wellcome) 226645/Z/22/Z
6 · The paper itself

Abstract

Apathy is a highly prevalent and disabling neuropsychiatric syndrome, but its multi-dimensional structure is a challenge for progress towards better identification and treatment. A crucial unresolved question is whether social disengagement reflects a distinct deficit in social motivation or a by-product of diminished initiative or emotional blunting. Previous studies have been constrained by modest sample sizes and limited use of apathy-specific instruments or phenotypically narrow cohorts. Here, we analysed item-level data from 11,243 individuals recruited across multiple centres, including 1154 neurological patients with Alzheimer's disease, Parkinson's disease, frontotemporal dementia, autoimmune encephalitis and small vessel disease, alongside people with depression and healthy adults. Across exploratory and confirmatory factor analyses, symptom-level network modelling, and lifespan analyses, social apathy consistently emerged as a coherent and separable dimension. This pattern was preserved across health, psychiatric, and neurocognitive cohorts, from adolescence through late life. Recognising social apathy as an independent domain reframes a central aspect of mental health-the motivation to connect, care, and act for others-and provides a foundation for more precise assessment and for interventions targeting both social and neurobiological mechanisms.

Indexed as

ApathyNeurocognitive DisordersSocial BehaviorAdolescentAdultAgedAged, 80 and overAlzheimer DiseaseFemaleFrontotemporal DementiaHumansMaleMiddle AgedParkinson DiseaseYoung Adult

Identifiers

PMID41951598
PMCPMC13184353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.